Sarah Shizuko Morimoto
No Rating Available
(Learn About Our Rating System)

Sarah Shizuko Morimoto, PsyD

Languages spoken: English

Clinical Locations

Huntsman Mental Health Institute

Huntsman Mental Health Institute Downtown Behavioral Health Clinic
Salt Lake City
801-583-2500

  • Dr. Morimoto is a licensed clinical neuropsychologist with expertise in diagnosis and treatment of mood disorders of late life. Her research encompasses the full range of digital cognitive intervention development, from identifying targeted, and clinically relevant cognitive deficits, and the underlying neural circuit dysfunction, to developing computerized paradigms, conducting clinical trials, to CR method development. Her intervention for geriatric depression NeuroFlex garnered national attention when her pilot trial was published in Nature Communications. Dr. Morimoto's work has been featured on National Public Radio; LX NBC News, KSL, LiveScience and the Salt Lake Tribune.

    Specialties

  • Dr. Morimoto is a licensed clinical neuropsychologist with expertise in diagnosis and treatment of mood disorders of late life. Her research encompasses the full range of digital cognitive intervention development, from identifying targeted, and clinically relevant cognitive deficits, and the underlying neural circuit dysfunction, to developing computerized paradigms, conducting clinical trials, to CR method development. Her intervention for geriatric depression NeuroFlex garnered national attention when her pilot trial was published in Nature Communications. Dr. Morimoto's work has been featured on National Public Radio; LX NBC News, KSL, LiveScience and the Salt Lake Tribune.

    Board Certification and Academic Information

    Academic Departments Population Health Sciences -Primary

    Education history

    Research Fellow Neurobiology of geriatric mood disorders - Weill Cornell Medical School Research Fellow
    Neuropsychology - New York-Presbyterian Weill Cornell Medical Center Postdoctoral Fellow
    Fellowship Neuropsychology - Beth Israel Deaconess Medical Center, Harvard Medical School Clinical Fellow
    Clinical Psychology - Pacific Graduate School of Psychology/Stanford University School of Medicine Psy.D.
    Graduate Training Clinical Psychology - Pacific Graduate School of Psychology/Stanford University School of Medicine M.S.
    Psychology - University of California, Berkeley B.A.

    Selected Publications

    Journal Article

    1. Lindbergh CA, Altizer R Jr, Grady JJ, Diniz BS, Kamath J, Steffens DC, Morimoto SS (2024). Computerized cognitive remediation of Long COVID in older adults. Int Psychogeriatr, 1-3. (Read full article)
    2. Vega JN, Newhouse PA, Conley AC, Szymkowicz SM, Gong X, Cote S, Mayer I, Taylor WD, Morimoto SS (2023). Use of focused computerized cognitive training (Neuroflex) to improve symptoms in women with persistent chemotherapy-related cognitive impairment. Digit Health, 9, 20552076231192754. (Read full article)
    3. Morimoto SS, Altizer RA, Gunning FM, Hu W, Liu J, Cote SE, Nitis J, Alexopoulos GS (2020). Targeting Cognitive Control Deficits With Neuroplasticity-Based Computerized Cognitive Remediation in Patients With Geriatric Major Depression: A Randomized, Double-Blind, Controlled Trial. Am J Geriatr Psychiatry, 28(9), 971-980. (Read full article)
    4. Respino M, Hoptman MJ, Victoria LW, Alexopoulos GS, Solomonov N, Stein AT, Coluccio M, Morimoto SS, Blau CJ, Abreu L, Burdick KE, Liston C, Gunning FM (2019). Cognitive Control Network Homogeneity and Executive Functions in Late-Life Depression. Biol Psychiatry Cogn Neurosci Neuroimaging, 5(2), 213-221. (Read full article)
    5. Bessette KL, Karstens AJ, Crane NA, Peters AT, Stange JP, Elverman KH, Morimoto SS, Weisenbach SL, Langenecker SA (2020). A Lifespan Model of Interference Resolution and Inhibitory Control: Risk for Depression and Changes with Illness Progression. Neuropsychol Rev, 30(4), 477-498. (Read full article)
    6. Victoria LW, Alexopoulos GS, Ilieva I, Stein AT, Hoptman MJ, Chowdhury N, Respino M, Morimoto SS, Kanellopoulos D, Avari JN, Gunning FM (2018). White matter abnormalities predict residual negative self-referential thinking following treatment of late-life depression with escitalopram: A preliminary study. J Affect Disord, 243, 62-69. (Read full article)
    7. Duff K, Anderson JS, Mallik AK, Suhrie KR, Atkinson TJ, Dalley BCA, Morimoto SS, Hoffman JM (2018). Short-term repeat cognitive testing and its relationship to hippocampal volumes in older adults. J Clin Neurosci, 57, 121-125. (Read full article)

  • News & Podcasts

    News

  • Clinical Trials